A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
In Vitro Evaluation of a Novel Derivative Combination Antimicrobial Ceftriaxone + Sulbactam + EDTA against Pan-resistant Gram-negative Bacteria at a 1,000-bedded Tertiary Care Teaching Hospital in Northern India
2020
Journal of Medical Academics
The global emergence of antimicrobial resistance among gram-negative (GN) species is a major public health concern. The emergence of pan-resistant superbugs has further led to a serious threat to global public health security. The infections with these bacterial strains are associated with prolonged hospitalization, disseminated infections, and mortality. Newer therapeutic strategies are urgently needed to be explored to avoid the problems of developing further resistance. Aim and objective:
doi:10.5005/jp-journals-10070-0056
fatcat:b6s4amidubbf3gbgoz5qmw66ma